United States · FDA National Drug Code directory
DIGOXIN
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51662-1217_5401664e-d0ba-6c02-e063-6394a90a6022
- Product NDC
- 51662-1217
- Form
- INJECTION
- Composition / generic term
- DIGOXIN
- Labeler
- HF Acquisition Co LLC, DBA HealthFirst
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180913
- Source listing expiry
- 20271231
Source-listed ingredients
- DIGOXIN — .25 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 mL in 1 AMPULE (51662-1217-1) · 51662-1217-1
- 25 POUCH in 1 CASE (51662-1217-3) / 1 mL in 1 POUCH (51662-1217-2) · 51662-1217-3
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →